IART Stock Analysis: Buy, Sell, or Hold?
IART - Integra LifeSciences Holdings
$16.74
0.15 (0.90%)
▲
5d:
-8.72%
30d:
-9.81%
90d:
+10.71%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IART trades at premium valuation expecting 6.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: IART trades at premium valuation expecting 6.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.95
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$11.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $16.74, which is considered oversold relative to its 30-day fair value range of $17.02 to $19.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.4) compared to its historical average (5.4). At these levels, the market is pricing in 6.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a strong uptrend. The price is currently testing key support at $16.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IART scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.56 (+16.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IART is in a strong uptrend. The price is currently testing key support at $16.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IART scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.56 (+16.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$17.02 -
$19.04
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.5%
Protect Your Profits
Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.56)
- BEARISH: Market expects 6.0% growth - appears too optimistic based on history
- CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-8.7%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$17.02 -
$19.04
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.31
(7.9%)
Support & Resistance Levels
Support Level
$16.44
Resistance Level
$18.65
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.43
Wall Street Target
$19.56
(+16.8%)
Revenue Growth (YoY)
0.8%
Earnings Growth (YoY)
0.4%
Profit Margin
-0.4%
Valuation Premium vs History
+6.0% premium
PE vs Historical
6.4 vs 5.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.0%
(market-implied from PE analysis)
1-Year Target
$17.74
(+6%)
2-Year Target
$18.81
(+12%)
3-Year Target
$19.94
(+19%)
3-Yr Target (if PE normalizes)
(PE: 6→5)
PE COMPRESSION
$16.75
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 6.0%)
$62.32
(+272%)
Base:
(SPY PE: 6.4, Growth: 6.0%)
$19.95
(+19%)
Bear:
(PE: 5.4, Growth: 6.0%)
$16.77
(+0%)
Share & Embed Analysis
Last updated: August 22, 2026 1:57 PM ET
Data refreshes hourly during market hours. Next update: 2:57 PM
Data refreshes hourly during market hours. Next update: 2:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
Advanced IART Option Strategies
Professional options setups generated by AI based on today's IART price and gamma walls.
